Back

Distinct phenotypic consequences of cholangiocarcinoma-associated FGFR2 alterations depend on biliary epithelial maturity

O'Loughlin, E.; Zhang, Y.; Chiasson-MacKenzie, C.; Dave, P.; Rheinbay, E.; Stott, S. L.; McClatchey, A. I.

2024-09-02 cancer biology
10.1101/2024.08.30.610360 bioRxiv
Show abstract

Epithelial cancers disrupt tissue architecture and are often driven by mutations in genes that play important roles in normal epithelial morphogenesis. The intrahepatic biliary system is an epithelial tubular network that forms within the developing liver via the de novo initiation and expansion of apical lumens. Intrahepatic biliary tumors (intrahepatic cholangiocarcinoma) commonly harbor activating genomic alterations in the FGFR2 receptor tyrosine kinase, which plays important roles in epithelial morphogenesis in other developmental settings. Using a physiologic and quantitative 3D model we demonstrate that FGFR signaling is important for biliary morphogenesis and that oncogenic FGFR2 fusions and in-frame deletions disrupt biliary architecture. Importantly, we show that the trafficking of and signaling from the FGFR2 mutants, as well as their phenotypic impacts, are governed by the epithelial state of the cell. Unexpectedly, we also found that distinct tumor-driving FGFR2 mutants disrupt biliary morphogenesis in completely different and clinically relevant ways, informing our understanding of morphogenesis and tumorigenesis and highlighting the importance of convergent studies of both. Summary statementUsing a physiologic 3D model of biliary tubulogenesis, Chiasson-MacKenzie et al. show that FGFR2 signaling is important for biliary morphogenesis and that different intrahepatic cholangiocarcinoma-causing FGFR2 alterations have unexpectedly distinct and epithelial state-specific impacts on biliary architecture.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.1%
18.4%
2
eLife
5422 papers in training set
Top 6%
10.0%
3
JCI Insight
241 papers in training set
Top 0.8%
4.8%
4
Molecular Biology of the Cell
272 papers in training set
Top 0.4%
4.8%
5
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 16%
4.3%
6
Gut
36 papers in training set
Top 0.2%
3.9%
7
Cell Reports
1338 papers in training set
Top 15%
3.6%
8
Developmental Cell
168 papers in training set
Top 5%
3.6%
50% of probability mass above
9
Hepatology Communications
21 papers in training set
Top 0.2%
3.0%
10
Gastroenterology
40 papers in training set
Top 0.7%
2.9%
11
PLOS Genetics
756 papers in training set
Top 6%
2.6%
12
Hepatology
18 papers in training set
Top 0.2%
2.1%
13
The Journal of Pathology
22 papers in training set
Top 0.2%
1.7%
14
Molecular Cancer Research
42 papers in training set
Top 0.3%
1.7%
15
Nature Communications
4913 papers in training set
Top 52%
1.6%
16
Scientific Reports
3102 papers in training set
Top 62%
1.5%
17
The Journal of Physiology
134 papers in training set
Top 1.0%
1.3%
18
Cancers
200 papers in training set
Top 3%
1.3%
19
Disease Models & Mechanisms
119 papers in training set
Top 2%
1.2%
20
PLOS ONE
4510 papers in training set
Top 61%
1.2%
21
Frontiers in Oncology
95 papers in training set
Top 3%
0.9%
22
iScience
1063 papers in training set
Top 27%
0.9%
23
Clinical Cancer Research
58 papers in training set
Top 2%
0.9%
24
Journal of Clinical Investigation
164 papers in training set
Top 5%
0.9%
25
Cancer Discovery
61 papers in training set
Top 2%
0.8%
26
Oncogenesis
12 papers in training set
Top 0.2%
0.7%
27
The American Journal of Pathology
31 papers in training set
Top 0.6%
0.7%
28
PLOS Computational Biology
1633 papers in training set
Top 26%
0.7%
29
PLOS Pathogens
721 papers in training set
Top 10%
0.6%
30
Genes & Development
90 papers in training set
Top 2%
0.6%